Background Traumatic brain injury (TBI) among elderly individuals poses a significant global
health concern due to the increasing ageing population. Methods We searched PubMed …

Background Traumatic brain injury (TBI) is a leading cause of death and long-term disability
worldwide. In addition to primary brain damage, systemic immune alterations occur, with …

Background and Objectives Traumatic brain injury (TBI) may be a chronic condition carrying
risk of future sequelae; few prospective studies examine long-term postinjury outcomes. We …

Objectives Examine quality of life (QoL) and psychological health after mild traumatic brain
injury (mTBI) in older people (65+ years) at 3-and 6-month follow-up and explore which …

Introduction: Neuroworsening may be a sign of progressive brain injury and is a factor for
treatment of traumatic brain injury (TBI) in intensive care settings. The implications of …

Introduction Two blood brain-derived biomarkers, glial fibrillar acidic protein (GFAP) and
ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), can rule out intracranial lesions in …

We aimed to find out which are the most frequent complications for patients who suffer a
traumatic brain injury (TBI) and its relation with brain biomarker levels. We conducted a …

Senescence is a negative prognostic factor for outcome and recovery following traumatic
brain injury (TBI). TBI‐induced white matter injury may be partially due to oligodendrocyte …

The kallikrein–kinin system is one of the first inflammatory pathways to be activated following
traumatic brain injury (TBI) and has been shown to exacerbate brain edema formation in the …

Background: Older adults (OAs) with mild traumatic brain injury (OA-mTBI) are a growing
population, but studies on long-term outcomes and quality of life are scarce. Our aim was to …